UK, med-tech company, Bedfont Scientific Ltd., is celebrating a brighter 2022 as the U.S. Food and Drug Administration (FDA) cleared its NObreath FeNO monitor for use in monitoring airway inflammation.
Bedfont's NObreath monitor for airway inflammation has been cleared for sale in the USA MAIDSTONE, England, Jan. 31, 2022 /PRNewswire/ UK, med-tech company, Bedfont Scientific Ltd.,
Bedfont and its sponsored football team, Medway United FC, have teamed up to donate 125 gifts to Medway hospital and 125 gifts to Children’s Cancer Charity, My Shining Star.
Bedfont signs first Smokerlyzer Medical Advisory Board member in time for No Smoking Day 2021 news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.